Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Animal Model Evidence The systemic evidence base is entirely preclinical: Pulmonary fibrosis (mouse model): Intraperitoneal GHK-Cu at 0.2-20 micrograms/g/day protected against bleomycin-induced lung fibrosis by inhibiting TGF-beta1/Smad signaling and reducing oxidative stress (PMID 31809714)
The medical conversations overlap too
One larger syringe (typically 3mL or 5mL) is used for transferring the bacteriostatic water into the peptide vial
Incline Peps does not provide instructions on how to use GHK-Cu, does not provide preparation advice and does not provide administration guidance
Many buyers begin by reviewing suppliers offering comprehensive medical solution ranges
US$ 23.78
US$ 28.78
US$ 26.32
US$ 28.02
US$ 28.10
US$ 20.10
